Date published: 2026-3-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

FKBP6 Inhibitors

FKBP6 inhibitors belong to a distinctive chemical class that targets the FK506-binding protein 6 (FKBP6), a member of the FK506-binding protein (FKBP) family. FKBP6 is a peptidyl-prolyl isomerase (PPIase) enzyme, which plays a crucial role in the regulation of protein folding and trafficking. The inhibition of FKBP6 involves disrupting its isomerase activity, which catalyzes the cis-trans isomerization of prolyl bonds in proteins. This particular function is essential for proper protein folding, stability, and interaction with other cellular components. By selectively inhibiting FKBP6, these compounds have the potential to modulate various cellular processes governed by FKBP6, influencing the conformational changes of target proteins. FKBP6 inhibitors are designed to interact specifically with the active site of FKBP6, preventing its engagement with substrate proteins. The chemical scaffolds of these inhibitors often incorporate functional groups that mimic the natural substrates of FKBP6, allowing for precise binding to the enzyme's catalytic site. The development of FKBP6 inhibitors is driven by the quest to understand the intricate regulatory networks within the cell, as well as to explore the potential implications of modulating FKBP6 activity on cellular functions.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Inhibits calcineurin by forming a complex with cyclophilins, which can indirectly affect FKBP6-involved pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Binds to FKBP12; this complex can influence mTOR pathways, which may indirectly affect FKBP6's protein interactions.

FK-506

104987-11-3sc-24649
sc-24649A
5 mg
10 mg
$78.00
$151.00
9
(1)

Binds to FKBP12, could disrupt protein complexes involving FKBP6 through competitive binding.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

A PPAR-gamma agonist that can modulate the transcription of genes potentially affecting FKBP6-related pathways.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Binds to Hsp90, potentially altering its interaction with client proteins and indirectly affecting FKBP6.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

Derivative of geldanamycin that also targets Hsp90, possibly influencing FKBP6-related protein folding.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$130.00
$583.00
$4172.00
$20506.00
20
(1)

Inhibits the proteasomal pathway, which might affect FKBP6's role in protein degradation.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

A proton pump inhibitor that can alter the cellular environment, potentially affecting FKBP6's function.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Affects endosomal acidification; this can alter protein trafficking and potentially FKBP6's associated pathways.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

A calcium channel blocker that could alter FKBP6-related signaling by affecting intracellular calcium levels.